CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 54
Clinical biomarkers of compliance for use in potentially reduced-risk product switching studies
(1) British American Tobacco (Investments) Limited, Research and Development, Southampton, U.K.; (2) ABF GmbH, Planegg, Germany
Preclinical assessments and clinical studies have shown significant reductions in toxicants in tobacco heating product (THP) aerosols compared to smoke from conventional cigarettes. Further studies to assess if these toxicant reductions translate to...